Evidence map›Paper›PMID 38958388›Full record

ArticleCNS neuroscience & therapeutics2024

Building evidence on safety of endovascular thrombectomy for patients under anticoagulation with vitamin K antagonists.

Li Gao, Xiaowei Sun, Peiying Li

Abstract readEditorialComment
In one paragraph

Article in CNS neuroscience & therapeutics, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

3 authors.

Li GaoDepartment of Neurology, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-3606-4837
Xiaowei SunClinical Research Center, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Peiying LiClinical Research Center, Ren Ji Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.ORCID 0000-0002-5721-9914

Funding

Innovative Research Team of High-level Local Universities in Shanghai SHSMU-ZLCX20211602National Natural Science Foundation of China 81801298National Natural Science Foundation of China 81971096National Natural Science Foundation of China 82061130224National Natural Science Foundation of China 91957111National Natural Science Foundation of China M-0671National Natural Science Foundation of China U22A20295New Frontier Technology Joint Research sponsored by Shanghai Shenkang Hospital Development Center SHDC12019102Shanghai Education Development Foundation and Shanghai Municipal Education Commission 20SG17Shanghai Municipal Education Commission-Gaofeng Clinical Medical 20181805Shanghai Municipal Science and Technology Committee 20XD1422400UK Academy of Medical Sciences NAF/R11/1010
6 · The paper itself

Abstract

A recent study by Brian Mac Grory and colleagues investigated the safety of endovascular thrombectomy (EVT) among patients under vitamin K antagonists (VKAs) use within 7 days prior to hospital admission. Through this retrospective, observational cohort study, they found prior VKA use did not increase the risk of symptomatic intracranial hemorrhage (sICH) overall. However, recent VKA use with a presenting international normalized ratio (INR) > 1.7 was associated with a significantly increased risk of sICH. Future large-scale randomized controlled trials should be conducted to further clarify the effects and feasibility of EVT therapy in ischemic stroke patients under anticoagulation.

Indexed as

AnticoagulantsEndovascular ProceduresThrombectomyVitamin KHumansIschemic StrokeRetrospective StudiesAnticoagulantsVitamin Kanticoagulationendovascular thrombectomyischemic strokesymptomatic intracranial hemorrhagevitamin K antagonists

Identifiers

PMID38958388
PMCPMC11220830

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.